Should peptide receptors radionuclide therapy (PRRT) be considered as a treatment of choice in functioning metastatic insulinomas? A review of literature and our center experience

ConclusionsIn conclusion, PRRT resulted to be a very promising treatment for inoperable malignant insulinomas, in terms of patients ’ quality of life improvement, clinical symptoms and tumor growth control. Further studies are needed, especially to evaluate its possible application as first-line therapy, in association with conventional therapies, which could lead to even better and longer-lasting results.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research